ArticleCancer immunology, immunotherapy : CII2020

Increased Th17 activation and gut microbiota diversity are associated with pembrolizumab-triggered tuberculosis.

Yun-Bin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.